Tennessee SB1426 mandates coverage for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and.
Tennessee SB1426 requires managed care organizations to cover medically necessary treatments for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS). Treatments must include antibiotics, medication, behavioral therapies, immunomodulating medicines, plasma exchange, and intravenous immunoglobulin. The act mandates that coverage cannot be limited over a recipient's lifetime or by policy duration.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.